大家在查： Terasen Hannes Cresp interregnums 中间包用 composix 828,000万 a chemical Khushab 爱德华·奥古斯

列奈

网络mitiglinide; Repaglinide

列奈

列奈

mitiglinide

列奈(mitiglinide)等。步长冠心舒通胶囊。

Repaglinide

...gelheim（勃林格殷格翰）公司联合开发的瑞格列奈（Repaglinide），1998 年在美国首次上市，2000 年已在中国上市，商品 …

1

RESULTS : The best therapeutic scheme was Novonorm and the rest were gliclazide , glipizide and glibenclamide in sequence.

结果：瑞格列奈组为最佳治疗方案，其次为格列齐特、格列吡嗪、格列苯脲。

2

To optimize the formula of the double-layer tablet of nateglinide rapid-release layer and metformin hydrochloride sustained-release layer.

优选由那格列奈速释层与盐酸二甲双胍缓释层组成的双层片处方。

4

Conclusion The reasonable formulation was obtained and preparation was simple , and the prepared tablets met the requirements .

结论筛选的处方合理，制备工艺简单可行，制备的瑞格列奈片符合制剂质量要求。

5

OBJECTIVE To establish the dissolution method for nateglinide tablets .

目的：建立那格列奈片的体外溶出度的测定方法。

6

ABSTRACT : Objective To evaluate the efficacy and safety of nateglinide, a new antidiabetic agent, in the treatment of type 2 diabetes .

摘要：目的评价那格列奈治疗 2 型糖尿病的有效性和安全性。

7

Conclusion Nateglinide is an effective and safe drug in treating type 2 diabetes.

结论那格列奈是安全有效的降血糖药物。

8

Repaglinide may be antagonized by CYP3A4 inducers (eg, rifampin ).

瑞格列奈可拮抗 CYP3A4 的诱导剂（如利福平）。

10

To study and evaluate the quality of Nateglinide tablets the formulation is screened.

对研制的那格列奈片进行质量评价与研究。

11

Objective : to study the nanotubes raigor column treatment of type 2 diabetic patients with clinical efficacy and safety of using .

目的：探讨瑞格列奈治疗 2 型糖尿病患者的临床疗效以及使用安全性。

12

HPLC determination of the concentrations of mitiglinide and its related substances

HPLC 法测定米格列奈钙原料药含量及有关物质

13

Bioequivalence and relative bioavailability of domestic and imported repaglinide tablets in healthy volunteers

国产与进口降糖药瑞格列奈片的生物等效性研究

14

Study of determination method on dissolution of nateglinide tablets

纳格列奈片溶出度测定方法的研究

15

Determination of Degree of Stripping of Nateglinide by Reversed Phase High Performance Liquid Chromatography

反相高效液相色谱法测定那格列奈片剂的溶出度

16

Preparation and quality investigation of nateglinide dispersible tablets

那格列奈分散片的制备及质量研究

17

Synthesis of nateglinide analogues and their bioactivity determination

那格列奈类似物的合成与活性测定

18

Determination of Chemical Constituent and Configuration of Repaglinide

瑞格列奈的化学结构测定

19

Study of the stability of nateglinide tablets

那格列奈片的稳定性研究

20

Determination of Nateglinide and its Related Substances by HPLC

HPLC 法测定那格列奈含量及有关物质

21

Comparison of Efficacy Between Nateglinide and Repaglinide in Treating Type 2 Diabetes: A Randomized Controlled Double-blind Clinical Trial

那格列奈与瑞格列奈治疗 2 型糖尿病的随机双盲对照研究

22

Synthesis and Hypoglycemic Activity of Mitiglinide Analogues

米格列奈类似物的合成及其降血糖作用

24

Metabolic characteristics of nateglinide in isolated hepatocytes of rat

那格列奈在大鼠游离肝细胞中的代谢特点

26

Repaglinide Treatment to Patient with Impaired Glucose Tolerance

瑞格列奈对糖耐量减低患者的干预治疗

27

Comparative study on the therapeutic efficacy of repaglinide versus acarbose in treatment of type 2 diabetes mellitus patients

瑞格列奈与阿卡波糖治疗 2 型糖尿病临床疗效比较研究

28

Progress in research of nateglinide and its analogues

那格列奈及其类似物的研究进展

29

Method for Dissolution Determination of Nateglinide Tablets in Vitro

那格列奈片溶出度测定方法

30

Determination of Residual Organic Solvents in Nateglinide by Capillary GC

那格列奈中有机溶剂残留量的毛细管气相色谱测定

热词推荐

大家在看